Andrew Berens
Stock Analyst at Leerink Partners
(4.87)
# 346
Out of 4,978 analysts
555
Total ratings
48.4%
Success rate
24%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $41 → $27 | $4.76 | +467.23% | 4 | Sep 10, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $1.83 | +282.51% | 26 | Aug 7, 2026 | |
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $56.78 | -8.42% | 13 | Aug 6, 2026 | |
| INCY Incyte | Reiterated: Buy | $103 → $155 | $124.75 | +24.25% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | n/a | $32.95 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $36.88 | +8.46% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.73 | - | 28 | Jun 2, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $46 → $51 | $24.53 | +107.91% | 2 | May 15, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 → $33 | $23.46 | +40.66% | 14 | May 15, 2026 | |
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $15.60 | +175.64% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $55 | $23.35 | +135.55% | 26 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $15.52 | +48.20% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.22 | +89.57% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $40 | $26.24 | +52.44% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $97 | $82.58 | +17.46% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $32.54 | +53.66% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.45 | +237.08% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $37.73 | -12.54% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.63 | n/a | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $2.88 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $18.84 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.82 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $8.16 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $348.08 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.10 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 | $8.35 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $0.38 | $0.365 | n/a | 25 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $174.90 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.48 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 → $25 | $3.45 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $12.65 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.70 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $9.39 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $98.01 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $9.87 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9178 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.81 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $40.01 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.70 | n/a | 2 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $147.68 | n/a | 3 | Dec 1, 2014 |
BridgeBio Oncology Therapeutics
Sep 10, 2026
Rated: Buy
Price Target: $41 → $27
Current: $4.76
Upside: +467.23%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $1.83
Upside: +282.51%
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $56.78
Upside: -8.42%
Incyte
Aug 3, 2026
Reiterated: Buy
Price Target: $103 → $155
Current: $124.75
Upside: +24.25%
Agios Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.95
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $36.88
Upside: +8.46%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.73
Upside: -
Damora Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $46 → $51
Current: $24.53
Upside: +107.91%
Immunome
May 15, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $23.46
Upside: +40.66%
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $15.60
Upside: +175.64%
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $23.35
Upside: +135.55%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $15.52
Upside: +48.20%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.22
Upside: +89.57%
Nov 19, 2025
Reiterated: Buy
Price Target: $24 → $40
Current: $26.24
Upside: +52.44%
Nov 17, 2025
Reiterated: Buy
Price Target: $70 → $97
Current: $82.58
Upside: +17.46%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $32.54
Upside: +53.66%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $4.45
Upside: +237.08%
Oct 21, 2025
Reiterated: Hold
Price Target: $30 → $33
Current: $37.73
Upside: -12.54%
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $20.63
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $33
Current: $2.88
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $18.84
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $3
Current: $2.82
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $9
Current: $8.16
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $348.08
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $3.10
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $18.00
Current: $8.35
Upside: n/a
Jun 11, 2025
Reiterated: Hold
Price Target: $1 → $0.38
Current: $0.365
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $174.90
Upside: n/a
Dec 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $70.48
Upside: n/a
Feb 7, 2023
Reiterated: Buy
Price Target: $67 → $25
Current: $3.45
Upside: n/a
Feb 7, 2023
Reiterated: Hold
Price Target: $20 → $15
Current: $12.65
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: n/a
Current: $11.70
Upside: n/a
May 7, 2021
Reiterated: Hold
Price Target: $10
Current: $9.39
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Reiterated: Hold
Price Target: $23
Current: $98.01
Upside: n/a
Jul 14, 2017
Reiterated: Hold
Price Target: $16 → $8
Current: $9.87
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.9178
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.81
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $40.01
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $12.70
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $147.68
Upside: n/a